Losartas 25 mg Intas Pharmaceuticals
€10.00
General introduction and principle of operation (Losartas 25 mg Intas Pharmaceuticals)
Losartas 25 mg from Intas Pharmaceuticals is a prescription medication primarily used to treat high blood pressure. It belongs to a class of drugs known as angiotensin II receptor blockers (ARBs), which help lower blood pressure by preventing angiotensin II from binding to its receptors. This action leads to vasodilation, reduced secretion of aldosterone, and improved renal function, contributing to lower cardiovascular risks.
The medication’s chemical name is 2-butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, with a molecular formula of C22H23ClN6O. It is stored at room temperature, away from moisture and heat, ensuring its efficacy remains intact.
Main components and active substances
Losartas 25 mg contains several key components that contribute to its therapeutic effect. The active substance is Losartan, which is crucial for the medication’s action in treating hypertension. Below are the key components and attributes:
- Active Substance: Losartan Potassium
- Strength: 25 mg
- Water Retention: Minimal to none
- Hepatotoxicity: Rare occurrences
- Trade Name: Cozaar
These components make Losartas 25 mg effective for managing high blood pressure and reducing associated health risks.
Mechanisms of action and expected results
Losartan operates mainly by inhibiting the action of angiotensin II, a hormone that narrows blood vessels and increases blood pressure. By blocking the receptors for angiotensin II, Losartas facilitates vasodilation, consequently lowering blood pressure. The expected results from using this medication include:
- Significant reduction in blood pressure levels
- Decreased risk of stroke and heart attacks in susceptible patients
- Improved overall cardiovascular health
Patients can expect these beneficial outcomes as part of a comprehensive treatment package.
Recommendations for use
For optimal results with Losartas 25 mg, it is important to follow medical advice on its use. Recommended usage includes:
- Start dosage typically at 50 mg once daily
- Monitor blood pressure regularly for effectiveness
- Adjustments may be made based on individual response and health condition
These guidelines ensure that users receive the maximum benefits from the medication while minimizing potential side effects.
Possible risks and contraindications (Losartas 25 mg Intas Pharmaceuticals)
While Losartas 25 mg is generally safe, it is important to be aware of its possible risks and contraindications. Commonly noted concerns include:
- Dizziness or light-headedness, particularly upon standing
- Contraindicated in patients with severe renal impairment
- Rare cases of hepatotoxicity
Patients should consult with their healthcare provider to evaluate these risks before starting treatment with Losartas 25 mg.
| Active substance | Losartan |
|---|---|
| Water Retention | Minimal to none |
| Hepatotoxicity | Rare |
| Lab Test | Blood pressure monitoring, renal function tests |
| Strength | 25mg |
| Also known as | Losartan Potassium |
| Blood pressure | Effectively reduces high blood pressure |
| Trade name | Cozaar |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol |
| Formula | C22H23ClN6O |
| Substance class | Angiotensin II receptor blocker (ARB) |
| Main action | Lowers blood pressure by blocking the receptors that angiotensin II acts on |
| Half-life | 1.5 to 2 hours, but the active metabolite has a half-life of 6 to 9 hours |
| Dosage (medical) | Typically starts at 50 mg once daily, can increase to 100 mg once daily depending on the patient's response and condition |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Lowers blood pressure, reduces the risk of stroke in patients with high blood pressure and left ventricular hypertrophy |
| Side effects | Dizziness, light-headedness, nasal congestion, back pain, and fatigue |
| Use in sports | None, as it does not enhance athletic performance |
| Manufacturer | Intas Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.